377 related articles for article (PubMed ID: 12398900)
21. Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells.
Wong E; DeLuca C; Boily C; Charleson S; Cromlish W; Denis D; Kargman S; Kennedy BP; Ouellet M; Skorey K; O'Neill GP; Vickers PJ; Riendeau D
Inflamm Res; 1997 Feb; 46(2):51-9. PubMed ID: 9085144
[TBL] [Abstract][Full Text] [Related]
22. Different catalytically competent arrangements of arachidonic acid within the cyclooxygenase active site of prostaglandin endoperoxide H synthase-1 lead to the formation of different oxygenated products.
Thuresson ED; Lakkides KM; Smith WL
J Biol Chem; 2000 Mar; 275(12):8501-7. PubMed ID: 10722687
[TBL] [Abstract][Full Text] [Related]
23. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
24. Slow-binding inhibition of human prostaglandin endoperoxide synthase-2 with darbufelone, an isoform-selective antiinflammatory di-tert-butyl phenol.
Johnson AR; Marletta MA; Dyer RD
Biochemistry; 2001 Jun; 40(25):7736-45. PubMed ID: 11412128
[TBL] [Abstract][Full Text] [Related]
25. Effects of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 specific inhibitors on mediator release from rat peritoneal mast cells.
Lau HY; Stenton GR
Inflamm Res; 1998; 47 Suppl 1():S22-3. PubMed ID: 9561398
[No Abstract] [Full Text] [Related]
26. Arginine 120 of prostaglandin G/H synthase-1 is required for the inhibition by nonsteroidal anti-inflammatory drugs containing a carboxylic acid moiety.
Mancini JA; Riendeau D; Falgueyret JP; Vickers PJ; O'Neill GP
J Biol Chem; 1995 Dec; 270(49):29372-7. PubMed ID: 7493972
[TBL] [Abstract][Full Text] [Related]
27. Systematic pharmacological approach to the characterization of NSAIDs.
Lora M; Denault JB; Leduc R; de Brum-Fernandes AJ
Prostaglandins Leukot Essent Fatty Acids; 1998 Jul; 59(1):55-62. PubMed ID: 9758208
[TBL] [Abstract][Full Text] [Related]
28. Effect of nimesulide action time dependence on selectivity towards prostaglandin G/H synthase/cyclooxygenase activity.
Vago T; Bevilacqua M; Norbiato G
Arzneimittelforschung; 1995 Oct; 45(10):1096-8. PubMed ID: 8595067
[TBL] [Abstract][Full Text] [Related]
29. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro.
Futaki N; Takahashi S; Yokoyama M; Arai I; Higuchi S; Otomo S
Prostaglandins; 1994 Jan; 47(1):55-9. PubMed ID: 8140262
[TBL] [Abstract][Full Text] [Related]
30. Molecular modelling of the differential interaction between several non-steroidal anti-inflammatory drugs and human prostaglandin endoperoxide H synthase-2 (h-PGHS-2).
Pouplana R; Lozano JJ; Ruiz J
J Mol Graph Model; 2002 Jan; 20(4):329-43. PubMed ID: 11858641
[TBL] [Abstract][Full Text] [Related]
31. Constitutive expression of prostaglandin endoperoxide G/H synthetase (PGHS)-2 but not PGHS-1 in hum an tracheal epithelial cells in vitro.
Walenga RW; Kester M; Coroneos E; Butcher S; Dwivedi R; Statt C
Prostaglandins; 1996 Nov; 52(5):341-59. PubMed ID: 8948503
[TBL] [Abstract][Full Text] [Related]
32. Kinetic basis for selective inhibition of cyclo-oxygenases.
Gierse JK; Koboldt CM; Walker MC; Seibert K; Isakson PC
Biochem J; 1999 May; 339 ( Pt 3)(Pt 3):607-14. PubMed ID: 10215599
[TBL] [Abstract][Full Text] [Related]
33. Analysis of prostaglandin G/H synthase-2 inhibition using peroxidase-induced luminol luminescence.
Forghani F; Ouellet M; Keen S; Percival MD; Tagari P
Anal Biochem; 1998 Nov; 264(2):216-21. PubMed ID: 9866686
[TBL] [Abstract][Full Text] [Related]
34. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin H synthase: protein synthesis-independent regulation in bovine aortic endothelial cells.
Rosenstock M; Danon A; Rimon G
Am J Physiol; 1997 Nov; 273(5):C1749-55. PubMed ID: 9374663
[TBL] [Abstract][Full Text] [Related]
36. Pharmacology of prostaglandin endoperoxide synthase isozymes-1 and -2.
Smith WL; Meade EA; DeWitt DL
Ann N Y Acad Sci; 1994 Apr; 714():136-42. PubMed ID: 8017762
[TBL] [Abstract][Full Text] [Related]
37. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
38. Differential allosteric regulation of prostaglandin H synthase 1 and 2 by arachidonic acid.
Swinney DC; Mak AY; Barnett J; Ramesha CS
J Biol Chem; 1997 May; 272(19):12393-8. PubMed ID: 9139685
[TBL] [Abstract][Full Text] [Related]
39. Stimulus dependence of non-steroidal antiinflammatory drug potency in a cellular assay of prostaglandin H synthase-2.
Hulkower KI; Otis ER; Wernimont AK; Bell RL
Eur J Pharmacol; 1997 Jul; 331(1):79-85. PubMed ID: 9274933
[TBL] [Abstract][Full Text] [Related]
40. A high level of cyclooxygenase-2 inhibitor selectivity is associated with a reduced interference of platelet cyclooxygenase-1 inactivation by aspirin.
Ouellet M; Riendeau D; Percival MD
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14583-8. PubMed ID: 11717412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
